Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cormack, J. E
Right arrow Articles by Morton, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cormack, J. E
Right arrow Articles by Morton, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 15, No. 2, 129-135 (2000)
DOI: 10.1177/026765910001500207

Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults

John E Cormack

Cardiac Surgery Department, Main Medical Center, Portland, Maine

Richard J Forest

Cardiac Surgery Department, Main Medical Center, Portland, Maine

Robert C Groom

Cardiac Surgery Department, Main Medical Center, Portland, Maine, groomr{at}mail.mmc.org

Jeremy Morton

Cardiac Surgery Department, Main Medical Center, Portland, Maine

Low hematocrit (Hct < 20) during cardiopulmonary bypass (CPB) is associated with higher mortality and other adverse outcomes. More frequently, low Hct is encountered in patients with small body size and women patients. This prompted us to take an aggressive approach in our care of these patients, involving a strategy for predicting patients at risk of low Hct, with the aid of an electronic worksheet that accurately predicts CPB Hct, and two prevention strategies: use of a low-prime CPB circuit (LP) for all adult patients with a body surface area (BSA) <1.7 m2 and use of autologous circuit priming (AP), in addition to the low-circuit volume in some patients. The two cohorts of patients in whom these techniques were employed were compared to a group matched for body size where our standard adult circuit (STD) was used. There were 233 patients in the standard group, 139 in the LP group, and 68 in the LP/AP group. The CPB circuit prime volume was 1710 ml for the STD group and 1110 ml for the LP group. Use of autologous priming techniques further reduced the prime volume by 545 ± 139 ml. The incidence of low Hct (<20%) during CPB was thus reduced from 70% to 15% (p = 0.001) when using both techniques together without increasing red blood cell (RBC) transfusions. These changes in perfusion management resulted in a reduction in the incidence of renal complications (STD = 9.4%, LP = 6.5% (ns) and LP/AP = 0%, p = 0.008) and a decrease in hospital mortality (STD = 9.8%, LP = 4.3, p = 0.05 and LP/AP = 0%, p=. 007). Matching the CPB circuit to the patient’s size and use of other prime-reduction strategies can increase Hct levels during CPB and improve outcomes in smaller patients, who are susceptible to increased risk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PerfusionHome page
R Issitt, T Cumberland, A Clements, and J Mulholland
Clinical evaluation of the Admiral 1.35m2 hollow-fibre membrane oxygenator
Perfusion, January 1, 2008; 23(1): 33 - 38.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
C. McKay
Perfusion Approaches to Blood Conservation
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 252 - 255.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al.
An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response.
J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3.
[Full Text] [PDF]


Home page
PerfusionHome page
K. McCusker, A. Chalafant, G. de Foe, S. Gunaydin, and V. Vijay
Influence of hematocrit and pump prime on cerebral oxygen saturation in on-pump coronary revascularization
Perfusion, May 1, 2006; 21(3): 149 - 155.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Dial, E. Delabays, M. Albert, A. Gonzalez, J. Camarda, A. Law, and D. Menzies
Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 654 - 654.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
H. Takai, K. Eishi, S. Yamachika, S. Hazama, T. Ariyoshi, and K. Nishi
Demonstration and Operative Influence of Low Prime Volume Closed Pump
Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. L. Frankel, S. C. Stamou, R. C. Lowery, E. I. Kapetanakis, P. C. Hill, E. Haile, and P. J. Corso
Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M A. Huybregts, R de Vroege, H M. Christiaans, A L Smith, and R C. Paulus
The use of a mini bypass system (Cobe Synergy) without venous and cardiotomy reservoir in a mitral valve repair: a case report
Perfusion, March 1, 2005; 20(2): 121 - 124.
[Abstract] [PDF]


Home page
PerfusionHome page
M. A Sobieski II, M. S Slaughter, D. E Hart, P. S Pappas, and A. J Tatooles
Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use
Perfusion, January 1, 2005; 20(1): 31 - 37.
[Abstract] [PDF]


Home page
PerfusionHome page
T Gourlay and P Connolly
Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective
Perfusion, July 1, 2003; 18(4): 225 - 231.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. C. Engoren, R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, and S. J. Durham
Effect of blood transfusion on long-term survival after cardiac operation
Ann. Thorac. Surg., October 1, 2002; 74(4): 1180 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
X. M. Mueller, D. Jegger, M. Augstburger, J. Horisberger, G. Godar, and L. K. von Segesser
A new concept of integrated cardiopulmonary bypass circuit
Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
R. C Groom
High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question
Perfusion, March 1, 2002; 17(2): 99 - 102.
[PDF]


Home page
PerfusionHome page
R A B. van Kempen, J M Gasiorek, K Bloemendaal, R P. S. van Leeuwen, and E R Bulder
Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehova's Witness: a case report
Perfusion, January 1, 2002; 17(1): 69 - 72.
[Abstract] [PDF]


Home page
PerfusionHome page
R. C Groom
High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question
Perfusion, September 1, 2001; 16(5): 339 - 343.
[PDF]


Home page
PerfusionHome page
A. H. E. Ean, T. S. Yan, T. Chan, E. James, and O. B. Chi
Centrifugation of salvaged pump blood is useful in reducing the amount of heparin re-infused into the patient
Perfusion, July 1, 2001; 16(4): 309 - 312.
[Abstract] [PDF]